Coyote Pharmaceuticals, Inc.

Coyote Pharmaceuticals, Inc.

Coyote Pharmaceuticals, Inc.

Date Founded



1455 Adams Drive,Suite 2116,Menlo Park, CA 94025

Type of Company



Holding Companies

Company Description

Coyote Pharmaceuticals, Inc. operates a biopharmaceutical company. It focuses on creating high value therapeutics for large unmet medical needs in several therapeutic categories including neurodegenerative, cardiovascular, oncologic, and inflammatory diseases. The company was founded by Hiroaki Serizawa in 2009 and is headquartered in Menlo Park, CA.

Executives & Employees


Board of Directors

Founder at DEFTA Partners

Principal at Coyote Pharmaceuticals, Inc.

Paths to Coyote Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
Coyote Pharmaceuticals, Inc.
Advisors & Consultants

Advisor at Telephus Biosciences

Details Hidden

DEFTA Corp. invests in companies located in U.S., U.K., Israel, Bangladesh, and Japan. The firm focuses on companies operating in the fields of medical devices, IT, healthcare services. They provide financing for seed and early stage capital requirements.

Details Hidden

Co-Founder at Coyote Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Coyote Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Coyote Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Coyote Pharmaceuticals, Inc..